Enzyme (MLN) is currently trading at $3.49 USD, reflecting a significant market adjustment with daily trading volume reaching $12.94K. The token shows distinct upside potential across multiple timeframes, with near-term resistance around $11.00, intermediate targets at $11.50, and longer-term objectives pushing toward $12.00 and beyond.

For traders managing risk, the $10.50 USDT level serves as a critical support zone, offering a retest opportunity should near-term momentum lose steam. These layered targets suggest MLN maintains structural buying interest despite recent price consolidation, making it a focus point for both bullish traders seeking breakout confirmation and risk-conscious participants tracking downside protection levels.